KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer

Liu, SS; Ye, ZW; Xue, VW; Sun, Q; Li, H; Lu, DS

Lu, DS (通讯作者),Shenzhen Univ, Carson Int Canc Ctr, Dept Pharmacol, Guangdong Prov Key Lab Reg Immun & Dis,Med Sch, Shenzhen 518055, Guangdong, Peoples R China.

BMC CANCER, 2023; 23 (1):